{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:59:46Z","timestamp":1789016386756,"version":"build-2803163510"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Patients with sickle cell disease (SCD) are at risk of fatal sepsis with encapsulated bacteria, such as <jats:italic toggle=\"yes\">Streptococcus pneumoniae<\/jats:italic>, because of the inherent autosplenectomy that occurs in SCD. This risk is thwarted with oral penicillin prophylaxis during the first 5 years of life, and with stringent vaccination against <jats:italic toggle=\"yes\">S. pneumoniae<\/jats:italic> alongside routine childhood immunization. But compared with the general African American pediatric population, the rate of invasive pneumococcal disease (IPD) in patients with SCD still remains high, resulting in hospitalization and fatality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Patients with SCD who developed IPD from 2004 up to 2013 were identified using microbiology records. Descriptive analysis of presence of risk factors for IPD, type of SCD, pneumococcal vaccination and prophylaxis status, clinical presentation, microbiological data, and the outcome of IPD was performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Eight patients with SCD developed IPD (7 bacteremia and 1 respiratory tract infection). Three of the 8 isolates underwent serotype analysis (15 C in 2 and 15A in 1), none covered with the current vaccination program. One patient had fatal outcome (15A).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Breakthrough cases of IPD may involve nonvaccine isolates, and seem to occur after 5 years of age when oral penicillin prophylaxis has been terminated.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mph.0000000000000858","type":"journal-article","created":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T20:51:17Z","timestamp":1495572677000},"page":"341-344","source":"Crossref","is-referenced-by-count":19,"title":["Invasive Pneumococcal Disease in Patients With Sickle Cell Disease"],"prefix":"10.1097","volume":"39","author":[{"given":"Pournima","family":"Navalkele","sequence":"first","affiliation":[{"name":"The Carman and Ann Adams Department of Pediatrics, Wayne State University, Children\u2019s Hospital of Michigan, Detroit"},{"name":"Pediatric Hematology and Oncology"},{"name":"Department of Pediatrics, Saint Louis University, Cardinal Glennon Children\u2019s Hospital, Saint Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00fclent","family":"\u00d6zg\u00f6nenel","sequence":"additional","affiliation":[{"name":"The Carman and Ann Adams Department of Pediatrics, Wayne State University, Children\u2019s Hospital of Michigan, Detroit"},{"name":"Pediatric Hematology and Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"McGrath","sequence":"additional","affiliation":[{"name":"The Carman and Ann Adams Department of Pediatrics, Wayne State University, Children\u2019s Hospital of Michigan, Detroit"},{"name":"Pediatric Infectious Diseases, Detroit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Lephart","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Detroit Medical Center University Laboratories, Detroit, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharada","family":"Sarnaik","sequence":"additional","affiliation":[{"name":"The Carman and Ann Adams Department of Pediatrics, Wayne State University, Children\u2019s Hospital of Michigan, Detroit"},{"name":"Pediatric Hematology and Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1045-1870(05)80007-X","article-title":"Initial approach to the child who presents with sickle-cell disease and fever","volume":"6","author":"Dreyer","year":"1995","journal-title":"Semin Pediatr Infect Dis"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/j.ijid.2009.05.010","article-title":"Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines","volume":"14","author":"Isaacman","year":"2010","journal-title":"Int J Infect Dis"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/INF.0b013e318124a494","article-title":"Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine","volume":"26","author":"Black","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","article-title":"Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance","volume":"15","author":"Moore","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ajem.2009.04.002","article-title":"Bacterial blood cultures in children with sickle cell disease","volume":"28","author":"Rogovik","year":"2010","journal-title":"Am J Emerg Med"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1097\/INF.0b013e3182a11808","article-title":"Active bacterial core surveillance T. Invasive pneumococcal disease among children with and without sickle cell disease in the United States, 1998 to 2009","volume":"32","author":"Payne","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00006454-199502000-00008","article-title":"Risk factors for invasive disease caused by Streptococcus pneumoniae among Alaska native children younger than two years of age","volume":"14","author":"Gessner","year":"1995","journal-title":"Pediatr Infect Dis J"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1056\/NEJM200003093421002","article-title":"Cigarette smoking and invasive pneumococcal disease. Active bacterial core surveillance team","volume":"342","author":"Nuorti","year":"2000","journal-title":"N Engl J Med"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jiph.2011.10.004","article-title":"Complications of PORT-A-CATH(R) in patients with sickle cell disease","volume":"5","author":"Alkindi","year":"2012","journal-title":"J Infect Public Health"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1001\/archpedi.1978.02120290068013","article-title":"Leukocyte counts in children with sickle cell disease. Comparative values in the steady state, vaso-occlusive crisis, and bacterial nfection","volume":"132","author":"Buchanan","year":"1978","journal-title":"Am J Dis Child"},{"key":"R11-20230918","first-page":"55","article-title":"Leucocyte counts in children with sickle cell anaemia usefulness of stable state values during infections","volume":"19","author":"Awogu","year":"2000","journal-title":"West Afr J Med"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/MPH.0b013e3182831016","article-title":"Bacteremia in febrile children with sickle cell disease","volume":"36","author":"\u00d6zg\u00f6nenel","year":"2014","journal-title":"J Pediatr Hematol Oncol"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1542\/peds.2012-2139","article-title":"Bacteremia risk and outpatient management of febrile patients with sickle cell disease","volume":"131","author":"Baskin","year":"2013","journal-title":"Pediatrics"},{"key":"R14-20230918","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jpeds.2010.11.025","article-title":"Increase in invasive Streptococcus pneumoniae infections in children with sickle cell disease since pneumococcal conjugate vaccine licensure","volume":"158","author":"McCavit","year":"2011","journal-title":"J Pediatr"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/INF.0b013e3182480fed","article-title":"Pneumococcal bacteremia in a vaccinated pediatric sickle cell disease population","volume":"31","author":"Ellison","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/INF.0b013e318275614b","article-title":"Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine","volume":"32","author":"Kaplan","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R17-20230918","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3390\/vaccines2010112","article-title":"Towards new broader spectrum pneumococcal vaccines: the future of pneumococcal disease prevention","volume":"2","author":"Lee","year":"2014","journal-title":"Vaccines"},{"key":"R18-20230918","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0022-3476(95)70154-0","article-title":"Discontinuing penicillin prophylaxis in children with sickle cell anemia. Prophylactic Penicillin Study II","volume":"127","author":"Falletta","year":"1995","journal-title":"J Pediatr"},{"key":"R19-20230918","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/j.ijid.2009.03.010","article-title":"Infection in sickle cell disease: a review","volume":"14","author":"Booth","year":"2010","journal-title":"Int J Infect Dis"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00043426-201707000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T04:11:06Z","timestamp":1695010266000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201707000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000000858","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]}}}